Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on

Tobias Luck1, Steffi G Riedel-Heller, Hanna Kaduszkiewicz

  • 1Department of Psychiatry, University of Leipzig, Leipzig, Germany. tobias.luck@medizin.uni-leipzig.de

Abstract

Insights

Mild cognitive impairment (MCI) is common in elderly patients seen by general practitioners (GPs). Early detection by GPs is crucial for preventing dementia progression.

Area of Science:

  • Gerontology
  • Neurology
  • General Practice

Background:

  • Mild cognitive impairment (MCI) is a significant risk factor for dementia.
  • Prevalence of MCI in general practitioner (GP) populations is not well-established.

Purpose of the Study:

  • Estimate the prevalence of original and modified MCI concepts in GP patients.
  • Investigate associations between MCI and sociodemographic, medical, and genetic factors (apoE ε4).

Main Methods:

  • A cohort of 3,327 individuals aged 75+ from GP practices was studied.
  • Structured clinical interviews were used for assessment.

Main Results:

  • Prevalence rates for MCI were 15.4% (original) and 25.2% (modified).
  • MCI prevalence increased with age.
  • Associations found with apoE ε4 allele, vascular diseases, and depressive symptoms.

Conclusions:

  • MCI is highly prevalent in elderly patients within primary care settings.
  • GPs play a vital role in the secondary prevention and management of cognitive decline.
  • Timely intervention by GPs can aid in delaying or preventing dementia.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...